LGC Clinical Diagnostics Inc

KPL was founded in 1979 to develop, manufacture and market high quality immunochemicals for life science and in vitro diagnostics. KPL was the first company to commercialize affinity purified secondary antibodies, a valuable tool for biological research and in vitro diagnostic testing. Since then KPL has introduced over 700 reagents and complete assay kits for protein visualization and nucleic acid detection that address the needs of cell biology, immunology, protein chemistry and molecular biology scientists.

Many leading diagnostic kit manufacturers utilize KPL reagents in a variety of commercially successful diagnostic kits for AIDS, tropical diseases, food testing and cancer. KPL's large-capacity production facility utilizes a comprehensive documentation system that assures adherence to the highest quality standards. KPL holds proprietary technologies and patents for immunoassay reagents that are used for visualization and detection.

SeraCare has served the global life sciences community, with distinction, for 25 years.

We develop and manufacture the highest quality, biologically-based products and we offer a broad range of related services, backed by expertise in virology, serology, immunology, and molecular biology.

At SeraCare, we are inspired when our products and services accelerate or improve your critical processes of validation, discovery, and production.

As a company, we have more than 100 years’ experience in linearity and calibration verification. That’s why we can stand behind our products and our service with a promise of 100% satisfaction.

Our experts are people who know our products in detail and can help you with any questions. We understand the strenuous demands of clinical laboratories and that is why we developed VALIDATE®, the product line with the most configurations designed for the most widely used instruments.

LGC Clinical Diagnostics consists of the following:
Maine Standards Company
SeraCare Life Sciences
The Native Antigen Company
Technopath Clinical Diagnostics.

Together we develop and manufacture a comprehensive portfolio of catalog and custom developed diagnostic quality solutions and component materials for the extended life sciences industry. We collaborate with IVD assay developers, and pharmaceutical, CRO and academic institutions in commercialization activities across the entire diagnostic pipeline – from concept and early-stage research, through expedited product development and onwards into routine clinical use. Laboratorians and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular and next generation sequencing rely on LGC Clinical Diagnostics’ products and services to support accurate and reliable patient diagnostic results.

Our 400+ employees operate in FDA-registered and ISO 13485-accredited facilities in Maine, Massachusetts and Maryland, USA, an ISO 9001-accredited facility in Oxford, England, and an ISO 13485-accredited facility in Tipperary, Ireland.

Maine Standards
SeraCare
Technopath Clinical Diagnostics
The Native Antigen Company

LGC was established 175 years ago. In November 2015, Maine Standards Company, LLC was acquired by LGC and is now branded as LGC Maine Standards.